AFPL
TMO icon

Advus Financial Partners, LLC’s Thermo Fisher Scientific TMO Stock Holding History

Advus Financial Partners, LLC’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$250K Buy
+499
New +$240K 0.06% 226
2026
Q1 		– Sell
-376
Closed -$218K – 257
2025
Q4 		$218K Buy
+376
New +$213K 0.05% 226
2025
Q2 		– Sell
-410
Closed -$204K – 269
2025
Q1 		$204K Buy
410
+20
+5% +$10.8K 0.06% 230
2024
Q4 		$203K Sell
390
-45
-10% -$24.7K 0.06% 222
2024
Q3 		$269K Sell
435
-23
-5% -$13.6K 0.08% 177
2024
Q2 		$253K Buy
458
+10
+2% +$5.73K 0.08% 169
2024
Q1 		$260K Buy
448
+16
+4% +$8.98K 0.08% 163
2023
Q4 		$229K Sell
432
-8
-2% -$3.87K 0.08% 162
2023
Q3 		$223K Buy
440
+27
+7% +$14.4K 0.09% 142
2023
Q2 		$215K Sell
413
-81
-16% -$43.7K 0.08% 147
2023
Q1 		$285K Buy
494
+17
+4% +$9.58K 0.12% 107
2022
Q4 		$263K Sell
477
-50
-9% -$26.5K 0.11% 117
2022
Q3 		$267K Buy
527
+55
+12% +$30.8K 0.14% 97
2022
Q2 		$256K Buy
472
+51
+12% +$28.1K 0.14% 104
2022
Q1 		$249K Buy
+421
New +$242K 0.13% 100
2021
Q3 		$236K Buy
+353
New +$194K 0.13% 85

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Advus Financial Partners, LLC's TMO Position: Q2 2026 in Review

Advus Financial Partners, LLC opened a new position in Thermo Fisher Scientific (TMO) in Q2 2026: 499 shares worth $250K. The stake represents 0.06% of the portfolio and ranks #226 among its holdings. This is a return to the name: Advus Financial Partners, LLC previously reported a position in TMO as recently as Q4 2025.

Advus Financial Partners, LLC first reported a position in TMO in Q3 2021 and has held it in 16 quarters since. The position peaked at $285K in Q1 2023. 2,613 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Advus Financial Partners, LLC held 499 shares of Thermo Fisher Scientific worth $250K as of Q2 2026.
  • Thermo Fisher Scientific was a new Advus Financial Partners, LLC position in Q2 2026.
  • Thermo Fisher Scientific made up 0.06% of Advus Financial Partners, LLC's portfolio in Q2 2026, its #226 holding.
  • Advus Financial Partners, LLC first reported a position in Thermo Fisher Scientific in Q3 2021 and has held it in 16 quarters since.
  • Advus Financial Partners, LLC's Thermo Fisher Scientific position peaked at $285K in Q1 2023.
  • 2,613 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Advus Financial Partners, LLC's 13F filing for Q2 2026, filed 25 Aug 2026.